Novozymes A/S B buy RudolfL
Start price
11.09.20
/
50%
€55.52
Target price
04.11.21
€63.00
Performance (%)
18.70%
End price
05.11.21
€65.90
Summary
This prediction ended on 05.11.21 with a price of €65.90. The BUY prediction by RudolfL finished with a performance of 18.70%. Dividends of €0.71 are taken into consideration when calculating the performance. RudolfL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novozymes A/S B | 2.132% | 2.132% | 51.430% | -10.365% |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
According to RudolfL what are the pros and cons of Novozymes A/S B for the foreseeable future?
Pros
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
ROE higher than 15% per year
Cons
Revenue decline/stagnation expected
Comments by RudolfL for this prediction
In the thread Novozymes A/s Nam. B diskutieren
Buy mit Kursziel 63,0
In the thread Trading Novozymes A/s Nam. B
Die von RudolfL gewählte maximale Laufzeit wurde überschritten
Stopped prediction by RudolfL for Novozymes A/S B
Novozymes A/S B
Start price
Target price
Perf. (%)
€46.87
26.01.20
26.01.20
€53.00
13.08.20
13.08.20
5.33%
13.08.20
13.08.20
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
Revenue decline/stagnation expected